- Home
- CVM vs DXR Comparison
CVM vs DXR Comparison
Compare CVM & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- DXR
- Stock Information
- Founded
- CVM 1983
- DXR 1970
- Country
- CVM United States
- DXR United States
- Employees
- CVM N/A
- DXR N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- DXR Medical/Dental Instruments
- Sector
- CVM Health Care
- DXR Health Care
- Exchange
- CVM Nasdaq
- DXR Nasdaq
- Market Cap
- CVM 53.1M
- DXR 46.9M
- IPO Year
- CVM 1987
- DXR N/A
- Fundamental
- Price
- CVM $6.71
- DXR $13.00
- Analyst Decision
- CVM
- DXR Strong Buy
- Analyst Count
- CVM 0
- DXR 1
- Target Price
- CVM N/A
- DXR $25.00
- AVG Volume (30 Days)
- CVM 91.8K
- DXR 5.5K
- Earning Date
- CVM 08-14-2025
- DXR 01-01-0001
- Dividend Yield
- CVM N/A
- DXR N/A
- EPS Growth
- CVM N/A
- DXR 3.46
- EPS
- CVM N/A
- DXR 0.36
- Revenue
- CVM N/A
- DXR $66,306.00
- Revenue This Year
- CVM N/A
- DXR N/A
- Revenue Next Year
- CVM N/A
- DXR N/A
- P/E Ratio
- CVM N/A
- DXR $36.05
- Revenue Growth
- CVM N/A
- DXR N/A
- 52 Week Low
- CVM $1.98
- DXR $6.55
- 52 Week High
- CVM $32.70
- DXR $14.00
- Technical
- Relative Strength Index (RSI)
- CVM 35.37
- DXR 51.16
- Support Level
- CVM $6.50
- DXR $12.52
- Resistance Level
- CVM $7.36
- DXR $13.13
- Average True Range (ATR)
- CVM 0.63
- DXR 0.73
- MACD
- CVM -0.06
- DXR -0.09
- Stochastic Oscillator
- CVM 18.32
- DXR 65.79
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.